Comparative costs of gemcitabine/cisplatin, paclitaxel/carboplatin and vinorelbine/cisplatin in the treatment of non-small cell lung cancer in Germany

被引：0
|
作者：
Bischoff, H
Hamann, M
Stynes, G
Bhalla, S
Tilden, D
Kielhorn, A
机构：
[1] Stabsstelle Med Management, Heidelberg, Germany
[2] Eli Lilly Germany, Bad Homburg, Germany
[3] M TAG Ltd, Hammersmith, England
[4] Eli Lilly, Windlesham, Surrey, England
来源：
VALUE IN HEALTH | 2004年 / 7卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)65750-6
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：674 / 674
页数：1
相关论文
共 50 条
  • [21] Phase I/II study of gemcitabine and vinorelbine plus cisplatin in non-small cell lung cancer
    Esteban, E
    Fra, J
    Sala, M
    Carrasco, J
    Corral, N
    Vieitez, JM
    Estrada, E
    Palacio, I
    Buesa, JM
    Lacave, AJ
    INVESTIGATIONAL NEW DRUGS, 2002, 20 (03) : 317 - 326
  • [22] Cisplatin plus vinorelbine or gemcitabine in patients with advanced non-small cell lung cancer: Pharmacoeconomic considerations
    Hughes, DA
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (11) : 1655 - 1655
  • [23] A Phase I Study of Vandetanib in Combination with Vinorelbine/Cisplatin or Gemcitabine/Cisplatin as First-Line Treatment for Advanced Non-small Cell Lung Cancer
    Blackhall, Fiona H.
    O'Brien, Mary
    Schmid, Peter
    Nicolson, Marianne
    Taylor, Paul
    Milenkova, Tsveta
    Kennedy, Sarah J.
    Thatcher, Nick
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (08) : 1285 - 1288
  • [24] Quality of life comparing carboplatin with cisplatin in the treatment of non-small cell lung cancer
    Snee, Michael
    EUROPEAN JOURNAL OF CANCER, 2018, 91 : 167 - 167
  • [25] Hypersensitivity reactions to carboplatin and cisplatin in non-small cell lung cancer
    Randall, J. Michael
    Bharne, Anjali A.
    Bazhenova, Lyudmila A.
    JOURNAL OF THORACIC DISEASE, 2013, 5 (02) : E53 - E57
  • [26] Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer
    C H Yang
    C M Tsai
    L S Wang
    Y C Lee
    C J Chang
    L T Lui
    S H Yen
    C Hsu
    A L Cheng
    M Y Liu
    S C Chiang
    Y M Chen
    K T Luh
    M H Huang
    P-C Yang
    R-P Perng
    British Journal of Cancer, 2002, 86 : 190 - 195
  • [27] Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer
    Yang, CH
    Tsai, CM
    Wang, LS
    Lee, YC
    Chang, CJ
    Lui, LT
    Yen, SH
    Hsu, C
    Cheng, AL
    Liu, MY
    Chiang, SC
    Chen, YM
    Luh, KT
    Huang, MH
    Yang, PC
    Perng, RP
    BRITISH JOURNAL OF CANCER, 2002, 86 (02) : 190 - 195
  • [28] Gemcitabine and cisplatin for advanced non-small cell lung cancer (NSCLC)
    Casal, J
    Grande, C
    Caeiro, M
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1083 - 1083
  • [29] Cisplatin, Gemcitabine and paclitaxel in advanced non-small cell lung cancer. A phase I study
    Comella, P
    Frasci, G
    Panza, N
    Lorusso, V
    Nicolella, GP
    Natale, M
    Manzione, L
    Bilancia, D
    Cioffi, R
    Maiorino, L
    Apicella, A
    Gravina, A
    Ruffolo, P
    De Rosa, V
    Comella, G
    ANNALS OF ONCOLOGY, 1998, 9 : 91 - 91
  • [30] Triplet chemotherapy with vinorelbine, gemcitabine, and cisplatin for advanced non-small cell lung cancer: a phase II study
    S Niho
    K Kubota
    K Goto
    H Ohmatsu
    T Matsumoto
    R Kakinuma
    Yutaka Nishiwaki
    British Journal of Cancer, 2002, 87 : 1360 - 1364
12345